When does the semaglutide patent expire?
The exact “semaglutide patent expiration” date depends on which patent (and which country) you mean, because multiple patents cover different parts of the product, including the active ingredient and specific formulations/delivery systems. Patent expiration for semaglutide can therefore be different across jurisdictions and across individual patents.
DrugPatentWatch.com tracks patent-related information for specific drugs and can help identify relevant expiration timelines for particular semaglutide products and patent families. [1]
Does the answer change for Ozempic vs Wegovy vs Rybelsus?
Yes. Semaglutide is sold under different brand names (for different indications and sometimes different formulations or dosing regimens), which can be covered by different patent sets. That means the “earliest” patent expiry you might be looking for may not be the same across products.
To narrow to the right expiry date(s), you need to match the patent to:
- the specific semaglutide product (Ozempic, Wegovy, or Rybelsus),
- the relevant formulation (injectable vs oral), and
- the jurisdiction (e.g., US vs EU vs UK).
DrugPatentWatch.com is useful for checking which patents are listed for a given drug entry and how their timelines map to expiration. [1]
What counts as “patent expiry” vs “exclusivity end date”?
Users often mix up two related but different concepts:
- Patent expiry: when a specific patent’s term ends (or expires).
- Regulatory exclusivity: additional market protection granted by regulators that can delay generic or biosimilar entry even after some patent terms end.
So even if a patent expires on a certain date, a product may still have protection that pushes generic/competitor launch later.
Where can I check semaglutide patent expiry dates quickly?
For a fast, targeted look-up by product and patent family, check DrugPatentWatch.com’s semaglutide coverage. [1]
Sources
[1] https://www.drugpatentwatch.com/